M&A Deal Summary

Integrated DNA Technologies Acquires Swift Biosciences

On March 11, 2021, Integrated DNA Technologies acquired life science company Swift Biosciences

Acquisition Highlights
  • This is Integrated DNA Technologies’ 2nd transaction in the Life Science sector.
  • This is Integrated DNA Technologies’ 3rd transaction in the United States.
  • This is Integrated DNA Technologies’ 1st transaction in Michigan.

M&A Deal Summary
Date 2021-03-11
Target Swift Biosciences
Sector Life Science
Buyer(s) Integrated DNA Technologies
Deal Type Add-on Acquisition

Target

Swift Biosciences

Ann Arbor, Michigan, United States
Swift Biosciences, Inc. is a provider in the development of Next-Generation Sequencing (NGS) library preparation genomics kits for academic, translational, and clinical research. Swift Biosciences was founded in 2014 and is based in Ann Arbor, Michigan.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integrated DNA Technologies

Coralville, Iowa, United States
Category Company
Sector Medical Products
DESCRIPTION

Integrated DNA Technologies, Inc. is a manufacturer of custom nucleic acids (i.e. building blocks of DNA and RNA) and assists researchers in advancing genomics technology, including synthetic biology and Next-Generation Sequencing. The company serves more than 80,000 customers across a diverse set of end markets including academic research, biotechnology, clinical diagnostics and pharmaceuticals.

DEAL STATS #
Overall 6 of 7
Sector (Life Science) 2 of 3
Type (Add-on Acquisition) 3 of 3
State (Michigan) 1 of 1
Country (United States) 3 of 4
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-10 ValueGene

San Diego, California, United States

ValueGene, Inc. is an oligonucleotide synthesis services company offers custom DNA and RNA oligonucleotide synthesis products, including PAGE and HPLC purification and modification services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-20 ArcherDX

Boulder, Colorado, United States

ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.

Buy $48M
Mergr

Product

Company

Legal